IL1A and TNF receptor 1-associated periodic fever syndrome: The beneficial effects of anakinra have been demonstrated in the treatment of a wide range of disorders, including auto-inflammatory diseases such as CAPS, TRAPS, or MKD/ HIDS [121], wherein the pathogenesis is associated with an excessive IL-1 expression.